What is the Corestemchemon Inc. stock price forecast?

Corestemchemon Inc. is currently trading at ₩3,380. View real-time AI analysis on Alpha Lenz.

What is Corestemchemon Inc. insider trading activity?

View the latest insider trading data for Corestemchemon Inc. on Alpha Lenz.

What is Corestemchemon Inc.'s P/E ratio?

Corestemchemon Inc.'s P/E ratio is -6.7.

Corestemchemon Inc.

KRX · 166480

₩3,380+10(+0.30%)

Ask about Corestemchemon Inc.'s future dividend policy...

Alpha Chat Insight

“Corestemchemon Inc. trades at a P/E of -6.7 (undervalued) with modest ROE of -51.7%.”

Ask for details →

Company Overview

Corestemchemon Inc. is a biotechnology company primarily focused on developing and commercializing innovative stem cell therapies. Its flagship product pipeline includes treatments aimed at addressing severe neurological and autoimmune disorders, leveraging advanced stem cell technology to offer potential therapeutic solutions where traditional treatments have limitations. A notable feature of Corestemchemon’s research includes its emphasis on neuroprotective and regenerative therapies that could significantly impact conditions like multiple sclerosis and amyotrophic lateral sclerosis (ALS). The company, part of the broader pharmaceuticals and healthcare sector, collaborates with medical institutions and research organizations to enhance its development capabilities. Corestemchemon Inc. plays a vital role in the biotechnology market by contributing to the advancement of regenerative medicine. Its pioneering work not only endeavors to improve patient outcomes but also pushes the boundaries of medical science in the quest for novel and effective treatment methodologies.

CEO양길안

Websitehttps://www.corestem.com

SectorHealthcare

IndustryBiotechnology

Employees354

Company Statistics

FY 2025

Profile

₩178,701,870,880Market Cap

₩20,158,947,960Revenue

52.87MShares Out

354Employees

Margins

-20.19%Gross

-103.58%EBITDA

-105.28%Operating

-132.91%Pre-Tax

-133.11%Net

Valuation

-6.66P/E

3.24P/B

8.86EV/Sales

-10.31EV/EBITDA

-11.22P/FCF

Growth (CAGR)

-23.98%Rev 3Yr

-5.22%Rev 5Yr

N/AOp Inc 3Yr

N/AOp Inc 5Yr

N/ANet Inc 3Yr

N/ANet Inc 5Yr

Returns

-23.35%ROA

-51.72%ROE

-21.85%ROIC

Financial Health

₩2,340,772,050Cash & Cash Equivalents

₩54,857,123,060Net Debt

103.67%Debt/Equity

N/AInterest Cov

Alpha Chat Insight

“Corestemchemon Inc. trades at a P/E of -6.7 (undervalued) with modest ROE of -51.7%.”

Ask for details →

Frequently Asked Questions

Corestemchemon Inc. (ticker: 166480) is a company listed on KRX in the Healthcare sector (Biotechnology). It has approximately 354 employees. Market cap is $178.7B.

The current price is ₩3,380 with a P/E ratio of -6.66x and P/B of 3.24x.

ROE is -51.72% and operating margin is -105.28%. Annual revenue is $20.2B.